Company intelligence / Profile preview

Lang Medikaments

United States

Ownership: Private
Development stage: Other

Overview

Lang Medikaments, Inc. was a contract manufacturing organization (CMO) that specialized in the production of sterile ophthalmic and parenteral pharmaceutical products. The company operated in the mid-2000s and was notably led by Larry W. Kranking as President from January 2005 to May 2006. Lang Medikaments focused on providing high-quality manufacturing solutions for complex sterile formulations, including injectables and eye care products. The company is primarily recognized in industry records through the subsequent leadership roles of its executives in the drug delivery and pharmaceutical operations sectors.

Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Lang Medikaments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lang Medikaments.

Explore the full profile